Effect of Macadamia Nut on Cardiometabolic Risk Factors

NCT ID: NCT03801837

Last Updated: 2023-03-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-24

Study Completion Date

2019-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study will test the effects of macadamia nuts on adiposity, and traditional and emergent risk factors of cardiometabolic disease in adult men and women

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose of this study is to investigate the effects of Macadamia nuts on body weight, adiposity, , oxidative stress, glucose, insulin an lipid levels. it will a randomized cross over study that will include two study diets (Macadamia nut diet and control diet) with a wash out period of 4 weeks in between. 40 subjects will be selected and randomized into either of the two phases. During the Macadamia nut diet phase subjects will be provided the appropriate portion of Macadamia nuts (15% of daily calories or 30-45 grams based on kcal requirement of the individual, instructions will be provided on how to incorporate nuts into the diet. this phase will last for 8 weeks. During the control diet phase, subjects will continue with their normal diet and abstain from eating nuts. subjects will be tested for various outcomes at baseline and twice at the end of each phase. The intervention will last for 5 months in total.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factor Heart Diseases Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Macadamia Nut Diet

This group will have their habitual diet supplemented with appropriate portion of Macadamia Nuts (15% of daily calories or 30-45 grams based on Kcal requirement of the individual)

Group Type ACTIVE_COMPARATOR

Macadamia Nut

Intervention Type DIETARY_SUPPLEMENT

Participants will be provided with the appropriate portion of macadamia nuts \[15% of daily calories or 30-45 grams based on kcal requirement of the individual\]

Control Diet

This group will continue with their Habitual Diet

Group Type PLACEBO_COMPARATOR

Control Diet

Intervention Type DIETARY_SUPPLEMENT

Participants will continue with their Habitual Diet during this part of the intervention

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Macadamia Nut

Participants will be provided with the appropriate portion of macadamia nuts \[15% of daily calories or 30-45 grams based on kcal requirement of the individual\]

Intervention Type DIETARY_SUPPLEMENT

Control Diet

Participants will continue with their Habitual Diet during this part of the intervention

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy men and post-menopausal women
* Overweight (BMI 25-\<40)
* Waist circumference ≥88.9 cm for women and ≥101.6 cm for men
* At least one of the following within the past year:
* Plasma triglycerides ≥150mg/dl
* Blood Pressure ≥130/85 mmHg or participants taking Antihypertensive medication
* Fasting glucose ≥100 mg/dL
* Low Density Lipoproteins\>= 130 mg/dl

Exclusion Criteria

* Nut allergy, any
* Significant chronic disease including: diabetes, congestive heart failure, renal failure, cirrhosis, or autoimmune disease
* Medications affecting lipid or glucose metabolism, immune modulators, or antibiotics in the last 6 months
* Mega-doses of lipid-lowering dietary supplements in the last 6 months
* Cancer in the last 10 years (with the exception on non-melanoma skin cancer)
* Pregnancy or lactation
* Weight change of \>10% of body weight in the last 3 months.
* Tobacco use
* Claustrophobia (may affect BOD POD testing)
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loma Linda University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joan Sabate,DrPH, MD

Professor of Nutrition

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joan Sabate, DrPH

Role: PRINCIPAL_INVESTIGATOR

Loma Linda University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University School of Public Health

Loma Linda, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Jones JL, Sabate J, Heskey C, Oda K, Miles F, Rajaram S. Macadamia nut effects on cardiometabolic risk factors: a randomised trial. J Nutr Sci. 2023 May 8;12:e55. doi: 10.1017/jns.2023.39. eCollection 2023.

Reference Type DERIVED
PMID: 37180485 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5190008

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of Nuts in Obese Children.
NCT03870984 TERMINATED NA
Almond for Physical Performance
NCT04787718 COMPLETED NA
Black Walnuts and Health
NCT04849949 COMPLETED NA